BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 20446065)

  • 1. Lung cancer screening: an update, discussion, and look ahead.
    Mazzone PJ
    Curr Oncol Rep; 2010 Jul; 12(4):226-34. PubMed ID: 20446065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lung cancer screening: examining the issues.
    Mazzone P
    Cleve Clin J Med; 2012 May; 79 Electronic Suppl 1():eS1-6. PubMed ID: 22614958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trade-off between benefits, harms and economic efficiency of low-dose CT lung cancer screening: a microsimulation analysis of nodule management strategies in a population-based setting.
    Treskova M; Aumann I; Golpon H; Vogel-Claussen J; Welte T; Kuhlmann A
    BMC Med; 2017 Aug; 15(1):162. PubMed ID: 28838313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening for lung cancer: U.S. Preventive Services Task Force recommendation statement.
    Moyer VA;
    Ann Intern Med; 2014 Mar; 160(5):330-8. PubMed ID: 24378917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Summaries for patients. Screening for lung cancer: recommendations from the U.S. Preventive Services Task Force.
    Ann Intern Med; 2014 Mar; 160(5):I-40. PubMed ID: 24378963
    [No Abstract]   [Full Text] [Related]  

  • 6. Principles of Cancer Screening.
    Pinsky PF
    Surg Clin North Am; 2015 Oct; 95(5):953-66. PubMed ID: 26315516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential of computer-aided diagnosis to improve CT lung cancer screening.
    Lee N; Laine AF; Márquez G; Levsky JM; Gohagan JK
    IEEE Rev Biomed Eng; 2009; 2():136-46. PubMed ID: 22275043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lung cancer screening and management.
    Jones GS; Baldwin DR
    Minerva Med; 2015 Dec; 106(6):339-54. PubMed ID: 26605556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-Effectiveness Analysis of Lung Cancer Screening in the United States: A Comparative Modeling Study.
    Criss SD; Cao P; Bastani M; Ten Haaf K; Chen Y; Sheehan DF; Blom EF; Toumazis I; Jeon J; de Koning HJ; Plevritis SK; Meza R; Kong CY
    Ann Intern Med; 2019 Dec; 171(11):796-804. PubMed ID: 31683314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness of lung MRI in lung cancer screening.
    Allen BD; Schiebler ML; Sommer G; Kauczor HU; Biederer J; Kruser TJ; Carr JC; Hazen G
    Eur Radiol; 2020 Mar; 30(3):1738-1746. PubMed ID: 31748855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Challenges and research opportunities for lung cancer screening in China.
    Wang Z; Wang Y; Huang Y; Xue F; Han W; Hu Y; Wang L; Song W; Jiang J
    Cancer Commun (Lond); 2018 Jun; 38(1):34. PubMed ID: 29880036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How to minimize harms of lung cancer screening.
    Veronesi G
    J Thorac Oncol; 2014 Nov; 9(11):e83. PubMed ID: 25436811
    [No Abstract]   [Full Text] [Related]  

  • 13. The cost-effectiveness of the Manchester 'lung health checks', a community-based lung cancer low-dose CT screening pilot.
    Hinde S; Crilly T; Balata H; Bartlett R; Crilly J; Barber P; Threlfall A; Tonge J; Booton R; Crosbie PA
    Lung Cancer; 2018 Dec; 126():119-124. PubMed ID: 30527175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The clinical effectiveness and cost-effectiveness of computed tomography screening for lung cancer: systematic reviews.
    Black C; Bagust A; Boland A; Walker S; McLeod C; De Verteuil R; Ayres J; Bain L; Thomas S; Godden D; Waugh N
    Health Technol Assess; 2006 Jan; 10(3):iii-iv, ix-x, 1-90. PubMed ID: 16409881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Benefits, harms and cost-effectiveness of cancer screening in Australia: an overview of modelling estimates.
    Lew JB; Feletto E; Wade S; Caruana M; Kang YJ; Nickson C; Simms KT; Procopio P; Taylor N; Worthington J; Smith D; Canfell K
    Public Health Res Pract; 2019 Jul; 29(2):. PubMed ID: 31384886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. What is the Optimum Screening Strategy for the Early Detection of Lung Cancer.
    Baldwin DR; Callister ME
    Clin Oncol (R Coll Radiol); 2016 Nov; 28(11):672-681. PubMed ID: 27544425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term Oncologic and financial implications of lung cancer screening.
    Pedersen JH; Sørensen JB
    Thorac Surg Clin; 2015 May; 25(2):223-9. PubMed ID: 25901566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The rationale for, and design of, a lung cancer screening program.
    Mazzone P
    Cleve Clin J Med; 2012 May; 79(5):337-45. PubMed ID: 22550076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current estimate of costs of lung cancer screening in the United States.
    Mauchley DC; Mitchell JD
    Thorac Surg Clin; 2015 May; 25(2):205-15. PubMed ID: 25901564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Computed tomography screening for lung cancer in the National Lung Screening Trial: a cost-effectiveness analysis.
    Black WC
    J Thorac Imaging; 2015 Mar; 30(2):79-87. PubMed ID: 25635704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.